Lavender, the plant and its oil, has been used continuously for thousands of years. It is native to the Mediterranean with several varieties that grow at different altitudes. Among the most versatile of oils, lavender is very effective at ...
Sometimes we need a lift during winter -- a dash of joy, fortification against illness or just a bit more verve. Clary sage may help. Topically, this essential oil is treasured as a stress reliever, antidepressant and aphrodisiac. It also ...
Tags: passion, beat, blue, invigorate, health, clary sage
The Brain & Behavior Research Foundation (BBRF) (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of president and CEO Dr Jeffrey Borenstein, has announced the latest ...
Tags: Narsad, BBRF, investigator, award
Many retailers offer discount prices on generics that may be cheaper than your co-pay. We asked our Secret Shoppers to price common generic drugs at more than 200 pharmacies around the U.S. and they found some real deals if you use cash or ...
Brainsway has gained US marketing rights for its Deep transcranial magnetic stimulation (TMS) device, designed for use in patients with depression, who have failed to respond to antidepressant medications, following the US Food and Drug ...
Nothing can sour a new pet-owner relationship like a shredded shoe or a chewed-up remote control. A dog's appetite for inedible objects can be exasperating and dangerous. Animal behavior consultant Arden Moore, author of "What Dogs Want: ...
Takeda Global Research & Development Center and Lundbeck have announced the FDA acceptance of vortioxetine new drug application (NDA) filing for major depressive disorder. The companies have also announced the proposal of Brintellix as ...
Tags: FDA, new drug application, NDA
Takeda Pharmaceutical Company and H. Lundbeck have submitted a new drug application (NDA) to the FDA for vortioxetine (Lu AA21004), an investigational drug for the treatment of major depressive disorder (MDD). Vortioxetine is under ...
Tags: Takeda Pharmaceutical Company, major depressive disorder, MDD
SureGene and PGXL Laboratories have joined forces to launch the SureGene Test for Antipsychotic and Antidepressant Response (STA2R), which is a pharmacogenetic test containing genetic markers for effectiveness of antipsychotic drug ...
Tags: STA2R, SureGene Test, pharmacogenetic test
Sunovion Pharmaceuticals has submitted two supplemental new drug applications (sNDAs) to the FDA seeking approval for the use of LATUDA (lurasidone HCl) as monotherapy and adjunctive therapy in adult patients with depressive episodes ...
Tags: FDA, sNDA, atypical class of drugs, bipolar depression
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud